Table 1.
Study Population Characteristics
| Characteristic | Participants, % (n = 769)a |
|---|---|
| Female sex | 26.3 |
| Age range, y | |
| 4–6 | 30.4 |
| 7–9 | 30.7 |
| 10–11 | 38.8 |
| Race | |
| Asian | 13.9 |
| Black | 14.0 |
| Hispanic | 32.8 |
| White | 33.5 |
| Other | 3.6 |
| Parental educational level no higher than high school diploma | 13.3 |
| Subsidy/income | |
| Medicaid (≤100% of the FPL) | 9.1 |
| CHIP (101%–250% of the FPL) | 16.8 |
| Unsubsidized | |
| ≤250% of the FPL | 21.7 |
| 251%–400% of the FPL | 14.0 |
| >400% of the FPL | 38.4 |
| Disease severity | |
| Received combination asthma medicationb | 17.5 |
| Prior asthma-related hospitalization or ED visit | 3.7 |
Abbreviations: CHIP, Children’s Health Insurance Program; ED, emergency department; FPL, federal poverty level.
a
All percentages were weighted for sampling proportions. Self-reported income data were missing for 16 participants; race, for 10; and parental educational level, for 3. Medicaid and CHIP income limits are for children and adolescents aged 6 to 18 years.
b
Children were coded as having received combination asthma medications if the parent reported use of a combination asthma medication (eg, inhaled corticosteroid plus long-acting β-agonist) and/or concurrent use of multiple controller medications (eg, inhaled corticosteroid and leukotriene modifier).